Skip to main content
Figure 2 | AIDS Research and Therapy

Figure 2

From: The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

Figure 2

The "resensitizing" effect of 76V could be observed in a variety of other patients before start of PI-containing therapy. Genotypic and phenotypic data of 10 representative PI-experienced patients were analysed by using five common resistance interpretation systems Stanford HIVdb 4.3.6; REGA v7.1.1, HIV-Grade 04/2008, ANRS 10/2007 and geno2pheno. Genotypic resistance results were compared to phenotypic resistance results derived from recombinant virus assay results and/or Virtual Phenotype™ analysis (Virco).

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us